Journal of Nutrition,Fasting and Health

Journal of Nutrition,Fasting and Health

The Effect of Fisetin Supplementation and High-Intensity Interval Training on Neurogenesis Markers in Aged Alzheimer's Model Mice

Document Type : Research Paper

Authors
Ali Jalali Dehkordi 1
Akbar Azamian Jazi 2
Khosro Jalali Dehkordi 3
1 PhD Student of Exercise Physiology, Department of Sport Sciences, Shahrekord University, Shahrekord, Iran.
2 Department of Sport Sciences, Shahrekord University, Shahrekord, Iran.
3 Department of Sport Physiology, Isfahan (Khorasgan) Branch, Islamic Azad University, Isfahan, Iran.
10.22038/jnfh.2024.82094.1528
Abstract
Introduction: Alzheimer's disease (AD) is associated with a marked reduction in brain-derived neurotrophic factor (BDNF) and fibronectin 1 (Fn1). This study investigates the effects of fisetin supplementation combined with high-intensity interval training (HIIT) on these neurogenesis markers in an aged mouse model of AD. Methods: In this experimental study, 30 aged C57BL/6 mice (weight: 30 g) with AD were randomly assigned to one of the five groups: (1) Control, (2) AD, (3) AD + Fisetin, (4) AD + HIIT, and (5) AD + HIIT + Fisetin. Alzheimer's disease was induced in the AD groups by injecting amyloid-beta (Aβ1-42) into the hippocampus. The HIIT protocol consisted of a 10-minute warm-up at 50-55% VO2 max, followed by seven intervals, each comprising 4 minutes at 80-90% VO2 max and 3 minutes at 65-75% VO2 max. Fisetin was administered at 20 mg/kg for eight weeks. Data were analyzed using one-way ANOVA with a significance level of P ≤ 0.05. Results: Significant differences were observed in BDNF, Fn1, and Aβ gene expression levels across the five groups of aged mice (p < 0.001). BDNF and Fn1 expression were significantly reduced in the AD groups compared to the healthy controls (p < 0.001). However, their expression levels increased significantly in the AD + Training + Fisetin, AD + Training, and AD + Fisetin groups compared to the AD-only group (p < 0.001). The AD + Training + Fisetin group exhibited the highest expression levels, followed by the AD + Training and AD + Fisetin groups (p < 0.001). Aβ expression was significantly reduced in all intervention groups, with the AD + Training + Fisetin group showing the most substantial decrease (p < 0.001). Conclusion: Combining HIIT and fisetin supplementation may promote cerebral neurogenesis in AD by reducing Aβ levels and enhancing BDNF and Fn1 gene expression. Notably, the combined intervention of HIIT and fisetin exhibits a more significant effect than either HIIT or fisetin alone, with HIIT being more effective than fisetin as a standalone treatment. Thus, the combination of HIIT and fisetin appears to be the most effective complementary approach for managing this disease.
Keywords
High-Intensity Interval Training
BDNF
Fn1
Fisetin
Alzheimer's Disease
Subjects
  1. Meamar R, Dehghani L, Ghasemi M, Saadatnia M, Basiri K, Faradonbeh NA, Javanmard SH. Enalapril protects endothelial cells against induced apoptosis in Alzheimer's disease. Journal of Research in Medical Sciences: the official journal of Isfahan University of Medical Sciences. 2013;18(Suppl 1):S1.
  2. Mayeux R. Epidemiology of neurodegeneration. Annual Review of Neuroscience. 2003;26(1):81-104.
  3. Hoyer S, Lee SK, Löffler T, Schliebs R. Inhibition of the neuronal insulin receptor An in vivo model for sporadic Alzheimer disease?. Annals of the New York Academy of Sciences. 2000;920(1):256-8.
  4. Sokoloff L. Relation between physiological function and energy metabolism in the central nervous system. Journal of Neurochemistry. 1977;29(1):13-26.
  5. Lee MK, Graham SN, Gold PE. Memory enhancement with posttraining intraventricular glucose injections in rats. Behavioral Neuroscience. 1988;102(4):591.
  6. Ardebili SMM, Yeghaneh T, Gharesouran J, Rezazadeh M, Farhoudi M, Ayromlou H, et al. Genetic association of TNF-α-308 G/A and-863 C/A polymorphisms with late onset Alzheimer's disease in Azeri Turk population of Iran. Journal of Research in Medical Sciences: The Official Journal of Isfahan University of Medical Sciences. 2011;16(8):1006.
  7. Jellinger KA. Recent advances in our understanding of neurodegeneration. Journal of Neural Transmission. 2009;116:1111-62.
  8. Kuipers SD, Bramham CR. Brain-derived neurotrophic factor mechanisms and function in adult synaptic plasticity: new insights and implications for therapy. Current Opinion in Drug Discovery and Development. 2006;9(5):580.
  9. Gliwińska A, Czubilińska-Łada J, Więckiewicz G, Świętochowska E, Badeński A, Dworak M, et al. The role of brain-derived neurotrophic factor (BDNF) in diagnosis and treatment of epilepsy, depression, schizophrenia, anorexia nervosa and Alzheimer’s disease as highly drug-resistant diseases: a narrative review. Brain Sciences. 2023;13(2):163.
  10. Fakhraei S, Almasi MR, Peeri M, Gharakhanlou R. The effect of 4-Week rehabilitation by aerobic exercise on hippocampus BDNF and TGF-β1 gene expressions in Aβ 1–42-induced rat model of Alzheimer’s disease. Journal of Clinical Neuroscience. 2022;95:106-11.
  11. Eggert S, Kins S, Endres K, Brigadski T. Brothers in arms: proBDNF/BDNF and sAPPα/Aβ-signaling and their common interplay with ADAM10, TrkB, p75NTR, sortilin, and sorLA in the progression of Alzheimer’s disease. Biological Chemistry. 2022;403(1):43-71.
  12. King V, Phillips J, Hunt-Grubbe H, Brown R, Priestley J. Characterization of non-neuronal elements within fibronectin mats implanted into the damaged adult rat spinal cord. Biomaterials. 2006;27(3):485-96.
  13. Kohyama T, Liu X, Wen F-Q, Kobayashi T, Abe S, Ertl R, et al. Nerve growth factor stimulates fibronectin-induced fibroblast migration. Journal of Laboratory and Clinical Medicine. 2002;140(5):329-35.
  14. King VR, Henseler M, Brown RA, Priestley JV. Mats made from fibronectin support oriented growth of axons in the damaged spinal cord of the adult rat. Experimental Neurology. 2003;182(2):383-98.
  15. Ten Dijke P, Hill CS. New insights into TGF-β–Smad signalling. Trends in Biochemical Sciences. 2004;29(5):265-73.
  16. Cordingley DM, Marquez I, Buchwald SC, Zeiler FA. Response of Central Nervous System Biomolecules and Systemic Biomarkers to Aerobic Exercise Following Concussion: A Scoping Review of Human and Animal Research. Neurotrauma Reports. 2024;5(1):708-20.
  17. Debove L, Bru N, Couderc M, Noé F, Paillard T. Physical activity limits the effects of age and Alzheimer's disease on postural control. Neurophysiologie Clinique/Clinical Neurophysiology. 2017;47(4):301-4.
  18. Abdullahi A, Wong TW-L, Ng SS-M. Understanding the mechanisms of disease modifying effects of aerobic exercise in people with Alzheimer’s disease. Ageing Research Reviews. 2024:102202.
  19. Puoyan-Majd S, Parnow A, Rashno M, Heidarimoghadam R, Komaki A. The Protective Effects of High-Intensity Interval Training Combined with Q10 Supplementation on Learning and Memory Impairments in Male Rats with Amyloid-β-Induced Alzheimer’s Disease. Journal of Alzheimer's Disease. 2024;99(s1):S67-S80.
  20. Montero-Odasso M, Zou G, Speechley M, Almeida QJ, Liu-Ambrose T, Middleton LE, et al. Effects of exercise alone or combined with cognitive training and vitamin D supplementation to improve cognition in adults with mild cognitive impairment: a randomized clinical trial. JAMA Network Open. 2023;6(7):e2324465-e.
  21. Nameni F, Rasoli Z. Investigating the effects of melilot extract and resistance training on protein expression APP in the hippocampus of Alzheimer's model rats. Sport Physiology & Management Investigations. 2024;15(4).
  22. Ahmad A, Ali T, Park HY, Badshah H, Rehman SU, Kim MO. Neuroprotective effect of fisetin against amyloid-beta-induced cognitive/synaptic dysfunction, neuroinflammation, and neurodegeneration in adult mice. Molecular Neurobiology. 2017;54:2269-85.
  23. Wang Y, Wu X, Ren W, Liu Y, Dai X, Wang S, et al. Protective effects of fisetin in an Aβ1-42-induced rat model of Alzheimer’s disease. Folia Neuropathologica. 2023;61(2):196-208.
  24. Gholipour P, Komaki A, Parsa H, Ramezani M. Therapeutic effects of high-intensity interval training exercise alone and its combination with ecdysterone against amyloid beta-induced rat model of Alzheimer’s disease: A behavioral, biochemical, and histological study. Neurochemical Research. 2022;47(7):2090-108.
  25. Maass A, Düzel S, Brigadski T, Goerke M, Becke A, Sobieray U, et al. Relationships of peripheral IGF-1, VEGF and BDNF levels to exercise-related changes in memory, hippocampal perfusion and volumes in older adults. Neuroimage. 2016;131:142-54.
  26. Gallen CL, D’Esposito M. Brain modularity: a biomarker of intervention-related plasticity. Trends in Cognitive Sciences. 2019;23(4):293-304.
  27. Lou S-j, Liu J-y, Chang H, Chen P-j. Hippocampal neurogenesis and gene expression depend on exercise intensity in juvenile rats. Brain Research. 2008;1210:48-55.
  28. Ossali A, Choobineh S, Suri R, Ravasi AA, Mostafavi H. The effect of twelve weeks aerobic exercise with moderate intensity on BDNF, and Short-term memory in 50-65 years old women with syndrome metabolic. Physiology of Sport and Physical Activity.2017;10(1):47-58.
  29. Wan C, Shi L, Lai Y, Wu Z, Zou M, Liu Z, et al. Long-term voluntary running improves cognitive ability in developing mice by modulating the cholinergic system, antioxidant ability, and BDNF/PI3K/Akt/CREB pathway. Neuroscience Letters. 2024;836:137872.
  30. Waller AP, George M, Kalyanasundaram A, Kang C, Periasamy M, Hu K, et al. GLUT12 functions as a basal and insulin-independent glucose transporter in the heart. Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease. 2013;1832(1):121-7.
  31. Nakhzari Khodakheir J, Haghighi AH, Hamedinia MR. The effects of combined exercise training with aerobic dominant and coenzyme q10 supplementation on serum BDNF and NGF levels in patients with Multiple Sclerosis. Journal of Arak University of Medical Sciences. 2018;21(3):94-103.
  32. Redolat R, Gresa PM. Reta a tu mente, desafía a tu cerebro: complejidad ambiental y salud cerebral. Revista INFAD de Psicología International Journal of Developmental and Educational Psychology. 2016;1(2):201-10.
  33. Lemańska-Perek A, Leszek J, Krzyżanowska-Gołą, b D, Radzik J, Ką, et al. Molecular status of plasma fibronectin as an additional biomarker for assessment of Alzheimer’s dementia risk. Dementia and Geriatric Cognitive Disorders. 2009;28(4):338-42.
  34. Jing-Ping L. Effects of fibronectin 1 on cell proliferation, senescence and apoptosis of human glioma cells through the PI3K/AKT signaling pathway. Cellular Physiology and Biochemistry. 2018;48(3):1382-96.
  35. Xiang L, Xie G, Ou J, Wei X, Pan F, Liang H. The extra domain A of fibronectin increases VEGF-C expression in colorectal carcinoma involving the PI3K/AKT signaling pathway. PloS One. 2012;7(4):e35378.
  36. Yousif NG. Fibronectin promotes migration and invasion of ovarian cancer cells through up‐regulation of FAK–PI 3 K/A kt pathway. Cell Biology International. 2014;38(1):85-91.
  37. Moosakhani A, Gaeini AA, Kordi M, Ravasi A. Examine Eight Weeks of Voluntary Exercise in Enriched Environment on the Expression of PI3K, Akt, Amyloid Beta Accumulation and Cell Death Rate in the Hippocampus of Male Wistar Rats with Alzheimer's Disease. Journal of Sport Biosciences. 2024.
  38. Zarin Afzal M, Kazemzadeh Y, Sedaghati S, Mirzaiyan S, Banaeifar A. The effect of interval training with curcumin supplementation on LRP1 and beta amyloid levels in rats with Alzheimer's disease. Ebnesina. 2021;23(4):4-14.
  39. Mohammadi ZF, Ebrahimzadeh M. The Effect of Six Weeks-Voluntary Wheel Running on Brain Amyloid Beta (1-42) Levels of Diabetic Rats. Zahedan Journal of Research in Medical Sciences. 2013;15(5).
  40. Nabizadeh F. Neuroprotective role of Fisetin in Alzheimer's disease: An overview of potential mechanism and clinical findings. Neurology Letters. 2024;3(Special Issue (Diagnostic and Therapeutic advances in Neurodegenerative diseases)):14-25.
Journal of Nutrition,Fasting and Health
Volume 13, Issue 1
Winter 2025
Pages 35-43

  • Receive Date 25 August 2024
  • Revise Date 11 October 2024
  • Accept Date 29 October 2024